Jade Biosciences, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +1,400.0% | +353.3% | +41.2% | +193.8% | -90.8% | |
| – | – | – | – | – | +796,436.6% | |
| – | -768.4% | – | +26.3% | -214.0% | – | |
| – | – | +7.7% | -27.2% | -100.0% | – | |
| – | – | – | +71.5% | +371.8% | -540.9% | |
| – | – | – | – | – | – | |
| – | +2,035.6% | -99.8% | +11,515.2% | -44.7% | +1,318.8% | |
| – | +4,585.9% | -164.1% | – | +837.8% | +85.7% | |
| – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.